Bradly Edgerton Phd Ccc Vancouver, WA - 98683

Bradly Edgerton Phd Ccc is categorized under Health Practitioners in Vancouver, WA and active since 2001.

Bradly Edgerton Phd Ccc was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Practitioners business, which does work in the B2B market, and is classified as a Health Practitioners, under code number 621399 by the NAICS.

If you are seeking more information, feel free to contact Bradly Edgerton at the company’s single location by writing to 406 Se 131st Avenue # 301c, Vancouver, Washington WA 98683 or by phoning (360) 256-4425. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bradly Edgerton Phd Ccc
Contact Person: Bradly Edgerton
Address: 406 Se 131st Avenue # 301c, Vancouver, Washington 98683
Phone Number: (360) 256-4425
Website Address: entclinic.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Health Practitioners
SIC Code: 8049
NAICS Code: 621399
Share This Business:

Bradly Edgerton Phd Ccc was started in 2001 to provide professional Health Practitioners under the SIC code 8049 and NAICS code 621399. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Bradly Edgerton for inquiries that concern Bradly Edgerton Phd Ccc by calling the company number (360) 256-4425, as your correspondence is most welcome. Additionally, the physical location of the single location of Bradly Edgerton Phd Ccc can be found at the coordinates 45.618381,-122.538199 as well as the street address 406 Se 131st Avenue # 301c in Vancouver, Washington 98683.

For its online presence, you may visit Bradly Edgerton Phd Ccc’s website at entclinic.com and engage with its social media outlets through on Twitter and on Facebook.